lobbying_filings_raw: 5cd37fa5-14c7-432a-ba3b-52e00a93bccf
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5cd37fa5-14c7-432a-ba3b-52e00a93bccf | Q3 | 8214 | CAPSTONE NATIONAL PARTNERS | 56321 | ATTERX BIOTHERAPEUTICS | 2025 | third_quarter | 2025-10-06T14:45:24-04:00 | 15000.0 | 0 | 0 | 0 | {"url": "https://lda.gov/api/v1/filings/5cd37fa5-14c7-432a-ba3b-52e00a93bccf/", "filing_uuid": "5cd37fa5-14c7-432a-ba3b-52e00a93bccf", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2025, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.gov/filings/public/filing/5cd37fa5-14c7-432a-ba3b-52e00a93bccf/print/", "filing_document_content_type": "text/html", "income": "15000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "William Stone", "dt_posted": "2025-10-06T14:45:24-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "501 Capitol Court NE", "registrant_address_2": "Suite 100", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20002", "registrant": {"id": 8214, "url": "https://lda.gov/api/v1/registrants/8214/", "house_registrant_id": 31113, "name": "CAPSTONE NATIONAL PARTNERS", "description": "public affairs", "address_1": "501 Capitol Court NE", "address_2": "Suite 100", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20002", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "WILLIAM STONE", "contact_telephone": "+1 202-551-1428", "dt_updated": "2026-01-08T09:20:18.253057-05:00"}, "client": {"id": 56321, "url": "https://lda.gov/api/v1/clients/56321/", "client_id": 56321, "name": "ATTERX BIOTHERAPEUTICS", "general_description": "Biotherapeutical development", "client_government_entity": null, "client_self_select": false, "state": "WI", "state_display": "Wisconsin", "country": "US", "country_display": "United States of America", "ppb_state": "WI", "ppb_state_display": "Wisconsin", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2023-04-03"}, "lobbying_activities": [{"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "FY26 Appropriations", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 63767, "prefix": null, "prefix_display": null, "first_name": "WILLIAM", "nickname": null, "middle_name": null, "last_name": "STONE", "suffix": null, "suffix_display": null}, "covered_position": "Chief of Staff, Congressman Dave Obey", "new": false}, {"lobbyist": {"id": 141519, "prefix": "mr", "prefix_display": "MR.", "first_name": "CHRISTOPHER", "nickname": null, "middle_name": "PAUL", "last_name": "CZARNECKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |